tiprankstipranks

John Schmid Insider Profile

4 Followers
John Schmid, CFO at Auspex Pharma, holds 46.24K shares in AnaptysBio (Ticker: ANAB), holds 0.00 shares in Poseida Therapeutics (Ticker: PSTX), holds 138.36K shares in Xeris Pharmaceuticals (Ticker: XERS).
tipranks
John Schmid

John Schmid
Auspex Pharma (ASPX)
CFO

Ranked #4,638 out of 100,285 Corporate Insiders

Profitable Transactions

100%
6 out of 6 Profitable Transactions

Average Return

+53.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1M
49.95%
30.18%
19.88%
A breakdown of John Schmid's holdings

Insider Roles

AnaptysBio
(ANAB)
Director
Xeris Pharmaceuticals
(XERS)
Director
Design Therapeutics
(DSGN)
Director
Roles that John Schmid holds in companies

Most Profitable Insider Trade

Stock:
Xeris Pharmaceuticals
(XERS)
Rating:Informative Buy
Date:May 10, 2024 - Today
Return:+93.10%
The most profitable trade made by John Schmid

John Schmid's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ASPX
Auspex Pharma
May 05, 2015
Uninformative Sell
NEOS
Neos Therapeutics
Mar 19, 2021
Uninformative Sell
$0.00
AnaptysBio
Jan 15, 2025
Director
Uninformative Buy
275.01K
$732.86K
Xeris Pharmaceuticals
Aug 13, 2024
Director
Informative Buy
10.11K
$442.75K
PSTX
Poseida Therapeutics
Jan 08, 2025
Uninformative Sell
$0.00
Design Therapeutics
Mar 25, 2024
Director
Informative Buy
99.66K
$291.65K
TSRX
Trius Therap
Aug 02, 2010
Uninformative Buy
List of latest transactions for each holding click on a transaction to see John Schmid's performance on stock

John Schmid insider profile FAQ

What is the percentage of profitable transactions made by John Schmid?
The percentage of profitable transactions made by John Schmid is 100%.
    What is the average return per transaction made by John Schmid?
    The average return per transaction made by John Schmid is 53.80%.
      What stocks does John Schmid hold?
      John Schmid holds: ASPX, NEOS, ANAB, XERS, PSTX, DSGN, TSRX stocks.
        What was John Schmid’s latest transaction?
        John Schmid latest transaction was an Uninformative Buy of $275.01K.
          What was John Schmid's most profitable transaction?
          John Schmid’s most profitable transaction was an Informative Buy of XERS stock on May 10, 2024. The return on the trade was 93.10%.
            What is John Schmid's role in Auspex Pharma?
            John Schmid's role in Auspex Pharma is CFO.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.